Department of Urology
Department of Urology

The Department of Urology, colloquially known as "Xian Niao Ke," is recognized as the birthplace of urology in China. It performed the first bladder lithotomy and the first transurethral lithotripsy in the country. In the 2019 Chinese Hospital Specialty Reputation Rankings, it ranked fifth nationally and first in South China. Currently designated as a National Clinical Key Specialty and a Guangdong Provincial Key Medical Discipline, it serves as the chair unit of the Urology Branch of the Chinese Medical Association, the incoming chair unit of the Urology Branch of the Guangdong Medical Association, the Guangdong Provincial Clinical Research Center for Urology, the Guangdong Provincial Urology Medical Quality Control Center, and the lead unit of the Guangdong Provincial Urology Medical Alliance. It is also an internationally accredited urology training base and minimally invasive technology training center, a site for doctoral and master's degree training and a postdoctoral research station at Sun Yat-sen University, and the lead unit of the Chinese Bladder Cancer Alliance.

Featured Medical Technology

The Department of Urology encompasses eight subspecialties: Oncology, Minimally Invasive Surgery, Stone Disease, Prostate and Lower Urinary Tract Diseases, Transplantation, Andrology, and Pediatric Urology. Among these, the Oncology, Minimally Invasive Surgery, and Stone Disease subspecialties have reached domestically leading levels. Clinically, minimally invasive techniques are comprehensively applied to urological diseases. The department pioneered in China a series of complex procedures, including laparoscopic radical cystectomy, robot-assisted posterior approach radical prostatectomy, laparoscopic inguinal lymphadenectomy, various single-port laparoscopic surgeries (having developed its own patented single-port trocar), and transvesical single-port laparoscopic vesicovaginal fistula repair. It was also the first in China to adopt fluorescent cystoscopy, non-invasive urine diagnostic techniques for bladder tumors, and transurethral en bloc resection of bladder tumors. The department innovated the oblique supine position for percutaneous nephrolithotomy and introduced the oblique cross-body position for treating upper urinary tract stones, proposing a holistic treatment strategy for urolithiasis. The introduction of the latest model extracorporeal shock wave lithotriptor has improved outcomes for complex stones and reduced surgical risks. Laser enucleation techniques for benign prostatic hyperplasia are performed, offering advantages of rapid recovery and minimal bleeding. The department also employs advanced lower urinary tract diagnostic and therapeutic technologies such as urodynamic studies and sacral neuromodulator implantation, and conducts kidney transplantation-related procedures. Serving as a consultation center for complex and critical urological conditions in South China, the department assists over 60 tertiary hospitals nationwide in performing various types of minimally invasive surgeries. The affiliated South China Minimally Invasive Training Center has become one of the most influential urological training centers in China, having trained over a thousand key urological professionals for the country.

Scientific Research Results

In terms of scientific research, the Department of Urology has secured 106 research grants over the past five years, including 26 from the National Natural Science Foundation of China (NSFC), ranking among the top in the domestic field. These include one NSFC Distinguished Young Scholar Project, one NSFC Key Program, one National Key Research and Development Program, and over 70 provincial/ministerial-level projects. The total research funding over the past five years exceeds 79 million RMB. Supported by these grants, the department has achieved significant breakthroughs in research areas such as bladder cancer and prostate cancer. Related research findings have been published in over 90 papers in high-impact international journals, including Journal of Clinical Investigation, European Urology, Nature Communications, Clinical Cancer Research, The Journal of Urology, and International Journal of Cancer. The research outcomes have been cited in European and Chinese urological disease diagnosis and treatment guidelines.

Expert Team
chief physician
Doctoral Supervisor